Abstract
The role of host genetic factors in the pathogenesis and outcome of hepatitis B virus (HBV) infection is not well known. We assessed the association of HLA and TNF (rs361525, rs1800629, rs1799724, rs1800630 and rs1799964) polymorphisms with HBV outcome in the South Indian population. Association of HLA polymorphism was analyzed in 90 individuals from each group, that is, spontaneous recovery (SR) and chronic-HBV (C-HBV) infection. The role of TNF polymorphisms was evaluated in 150 subjects with SR and 137 patients with C-HBV infection. After adjusting for age and sex, HLA-DRB1*07:01 was strongly associated with chronicity (corrected P-value (pc) <0.005, odds ratio (OR) 3.76, 95% confidence interval (CI) 1.84–7.68). The rs1800630 genotype was associated with HBV outcome in codominant (pc<0.01, OR=1.99, 95% CI 1.30–3.05) and dominant (pc<0.01, OR=2.28, 95% CI 1.35–3.84) analyzing models after adjusting for age and sex. Similarly, the rs1799964 genotype was associated with HBV outcome in codominant (pc=0.01, OR=1.57, 95% CI 1.09–2.27) and dominant (pc<0.01, OR=2.21, 95% CI 1.27–3.83) analyzing models. Haplotype analysis (rs1799964/rs1800630/rs1799724/rs1800629/rs361525) revealed that the CACGG haplotype was strongly associated with C-HBV infection (P=0.0004). Our study suggests that inheritance of HLA and TNF polymorphisms might explain the outcome of HBV infection in the South Indian population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Maddrey WC . Hepatitis B: an important public health issue. J Med Virol 2000; 61: 362–366.
Lavanchy D . Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97–107.
Lee WM . Hepatitis B virus infection. N Engl J Med 1997; 337: 1733–1745.
Datta S . An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J 2008; 5: 156.
Pitchappan RM . Castes, migration, immunogenetics and infectious diseases in south India. Community Genet 2002; 5: 157–161.
Basu A, Mukherjee N, Roy S, Sengupta S, Banerjee S, Chakraborty M et al. Ethnic India: a genomic view, with special reference to peopling and structure. Genome Res 2003; 13: 2277–2290.
Verma G, Dalai P, Bapat M, Rathi P, Abraham P . Familial clustering of hepatitis B infection: study of a family. Indian J Gastroenterol 2003; 22: 22–23.
Chisari FV, Ferrari C . Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29–60.
Rehermann B, Nascimbeni M . Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev 2005; 5: 215–229.
Huang CF, Lin SS, Ho YC, Chen FL, Yang CC . The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol 2006; 3: 97–106.
Zganiacz A, Santosuosso M, Wang J, Yang T, Chen L, Anzulovic M et al. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest 2004; 113: 401–413.
Danis VA, Millington M, Hyland VJ, Grennan D . Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303–310.
Wilson AG, di Giovine FS, Blakemore AI, Duff GW . Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353.
D’Alfonso S, Richiardi PM . A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39: 150–154.
Zimmerman PA, Guderian RH, Nutman TB . A new TNFA promoter allele identified in South American Blacks. Immunogenetics 1996; 44: 485–486.
Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998; 52: 359–367.
Kroeger KM, Carville KS, Abraham LJ . The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391–399.
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW . Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195–3199.
Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV . CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol 2010; 184: 287–295.
Chen Y, Wei H, Gao B, Hu Z, Zheng S, Tian Z . Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J Viral Hepat 2005; 12: 38–45.
Cavanaugh VJ, Guidotti LG, Chisari FV . Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol 1998; 72: 2630–2637.
Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV . Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284: 825–829.
Singh R, Kaul R, Kaul A, Khan K . A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007; 13: 1770–1787.
Balakrishnan K, Pitchappan RM, Suzuki K, Kumar US, Santhakumari R, Tokunaga K . HLA affinities of Iyers, a Brahmin population of Tamil Nadu, South India. Hum Biol 1996; 68: 523–537.
Shanmugalakshmi S, Balakrishnan K, Manoharan K, Pitchappan RM . HLA-DRB1*, -DQB1* in Piramalai Kallars and Yadhavas, two Dravidian-speaking castes of Tamil Nadu, South India. Tissue Antigens 2003; 61: 451–464.
Shankarkumar U, Sridharan B . HLA DRB1* and DQB1* allelic diversity among Nadars: a primitive south Indian Dravidian caste group. Hum Immunol 2004; 65: 847–854.
Thursz M . Pros and cons of genetic association studies in hepatitis B. Hepatology (Baltimore, MD) 2004; 40: 284–286.
Almarri A, Batchelor JR . HLA and hepatitis B infection. Lancet 1994; 344: 1194–1195.
Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, Kaslow RA . HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology (Baltimore, MD) 2004; 39: 978–988.
Desombere I, Willems A, Leroux-Roels G . Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 1998; 51: 593–604.
McDermott AB, Zuckerman JN, Sabin CA, Marsh SG, Madrigal JA . Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997; 50: 8–14.
McDermott AB, Cohen SB, Zuckerman JN, Madrigal JA . Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine. Vaccine 1999; 17: 330–339.
Potter DM . A permutation test for inference in logistic regression with small- and moderate-sized data sets. Stat Med 2005; 24: 693–708.
Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, Kim LH et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 2003; 12: 2541–2546.
Kao PC, Wu JF, Ni YH, Lin YT, Chen HL, Hsu SH et al. Tumour necrosis factor-alpha promoter region polymorphisms affect the course of spontaneous HBsAg clearance. Liver Int 2010; 30: 1448–1453.
Skoog T, van’t Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J et al. A common functional polymorphism (C—>A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999; 8: 1443–1449.
Tsuchiya N, Tokushige K, Yamaguchi N, Hasegawa K, Hashimoto E, Yamauchi K et al. Influence of TNF gene polymorphism in patients with acute and fulminant hepatitis. J Gastroenterol 2004; 39: 859–866.
Li Z, Li HQ, Yan Y, Liu Y, Hao W, Niu JQ et al. Association between genetic polymorphism of tumor necrosis factor and chronic severe hepatitis B in patients]. Zhonghua Yi Xue Za Zhi 2007; 87: 2105–2108.
Lu LP, Li XW, Liu Y, Sun GC, Wang XP, Zhu XL et al. Association of -238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J Gastroenterol 2004; 10: 1810–1814.
Li HQ, Li Z, Liu Y, Li JH, Dong JQ, Gao JR et al. Association of-238G/A and -857C/T polymorphisms of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection. Biomed Environ Sci 2006; 19: 133–136.
Zhu QR, Ge YL, Gu SQ, Yu H, Wang JS, Gu XH et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J (Engl) 2005; 118: 1604–1609.
Selvaraj P, Sriram U, Mathan Kurian S, Reetha AM, Narayanan PR . Tumour necrosis factor alpha (−238 and −308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis (Edinburgh, Scotland) 2001; 81: 335–341.
Amarapurpar DN, Patel ND, Kankonkar SR . HLA class II genotyping in chronic hepatitis B infection. J Assoc Physicians India 2003; 51: 779–781.
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G et al. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996; 23: 1725–1728.
Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 2002; 97: 2086–2092.
Kubota T, McNamara DM, Wang JJ, Trost M, McTiernan CF, Mann DL et al. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. Circulation 1998; 97: 2499–2501.
Ye S, Dhillon S, Ke X, Collins AR, Day IN . An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001; 29: E88–E88.
Grutters JC, Sato H, Pantelidis P, Lagan AL, McGrath DS, Lammers JW et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002; 165: 1119–1124.
Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 2005; 21: 263–265.
Qin ZS, Niu T, Liu JS . Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet 2002; 71: 1242–1247.
Acknowledgements
We specially extend our gratitude to the staff of virology and all participants in our study. The study of TNF polymorphism was funded by a Fluid Research Grant (Grant No. 5821) from the Christian Medical College, Vellore. The study of HLA polymorphism with the outcome of HBV infection was funded by DBT Grant (BT/PR10280/MED/29/58/2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Fletcher, G., Samuel, P., Christdas, J. et al. Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population. Genes Immun 12, 552–558 (2011). https://doi.org/10.1038/gene.2011.32
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gene.2011.32
Keywords
This article is cited by
-
Synergetic Interaction of HLA-DRB1*07 Allele and TNF-Alpha − 863 C/A Single Nucleotide Polymorphism in the Susceptibility to Systemic Lupus Erythematosus
Indian Journal of Clinical Biochemistry (2021)
-
Virological and Clinical Characteristics of Hepatitis B Virus Genotype A
Journal of Gastroenterology (2018)
-
Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections
Clinical Reviews in Allergy & Immunology (2016)